Azmi Yerlikaya
Turkey Kutahya Health Sciences University
ORCID
Published in 2018
- Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer
- Authors: Nuray Erin, Nur Ogan, Azmi Yerlikaya
- Journal: Breast Cancer Research and Treatment
ORCID
Published in 2017
- Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
- Authors: -
- Journal: Cytotechnology
ORCID
Published in 2016
- A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib
- Authors: AZMI YERLIKAYA, ELIF ERDOĞAN, EMRAH OKUR, ŞERIFE YERLIKAYA, BIRCAN SAVRAN
- Journal: Oncology Letters
ORCID
Published in 2016
- Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3
- Authors: BEKIR ARAS, AZMI YERLIKAYA
- Journal: Oncology Letters
ORCID
Published in 2015
- A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line
- Authors: Azmi Yerlikaya, Emrah Okur, Ahmet Tarık Baykal, Ceyda Acılan, İhsan Boyacı, Engin Ulukaya
- Journal: Journal of Proteomics
ORCID
Published in 2014
- Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro
- Authors: Engin Ulukaya, Mehmet Sarimahmut, Buse Cevatemre, Ferda Ari, Azmi Yerlikaya, Konstantinos Dimas
- Journal: Biomedicine and Pharmacotherapy
ORCID
Published in 2014
- Anticancer agent Ukraine and bortezomib combination is synergistic in 4T1 breast cancer cells
- Authors: Bircan Savran, Azmi Yerlikaya, Elif Erdoğan, Osman Genç
- Journal: Anti-Cancer Agents in Medicinal Chemistry
ORCID
Published in 2014
- Data for a proteomic analysis of p53-independent induction of apoptosis by bortezomib
- Authors: -
- Journal: Data in Brief
ORCID
Published in 2014
- Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish population
- Authors: C. Ayada, Ü. Toru, O. Genç, A. Yerlikaya, S. Sahin, S. Turgut, G. Turgut
- Journal: Genetics and Molecular Research
ORCID
Published in 2013
- Effect of bortezomib in combination with cisplatin and 5-fluorouracil on 4T1 breast cancer cells
- Authors: AZMI YERLIKAYA, SAYIT ALTIKAT, REYHAN IRMAK, FATMA ZEHRA CAVGA, SULTAN AYSUN KOCACAN, IHSAN BOYACI
- Journal: Molecular Medicine Reports